The impact of increasing karyotypic complexity and evolution on survival in CLL patients treated with ibrutinib.
暂无分享,去创建一个
M. Grever | J. Byrd | N. Heerema | L. Abruzzo | A. Ruppert | K. Rogers | A. Kittai | J. Woyach | Kyle A. Beckwith | Ying Huang | D. Bond | S. Bhat | D. Goldstein | Cecelia R. Miller | Cecelia R Miller